e-learning
resources
Amsterdam 2011
Wednesday, 28.09.2011
Physiological basis of respiratory disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Site of ROS production by mitochondria of skeletal muscle of patients with COPD
L. Puente-Maestu, J. de Miguel, L. Álvarez-Sala, A. Tejedor, A. Lázaro, E. Ojeda, T. Gómez, A. Agustí (Madrid, Barcelona, Spain)
Source:
Annual Congress 2011 - Physiological basis of respiratory disease
Session:
Physiological basis of respiratory disease
Session type:
Poster Discussion
Number:
4738
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Puente-Maestu, J. de Miguel, L. Álvarez-Sala, A. Tejedor, A. Lázaro, E. Ojeda, T. Gómez, A. Agustí (Madrid, Barcelona, Spain). Site of ROS production by mitochondria of skeletal muscle of patients with COPD. Eur Respir J 2011; 38: Suppl. 55, 4738
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Role of complex I and III in the production of reactive oxygen species by mitochondria of peripheral muscle in COPD subjects
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009
Altered mitochondrial reactive oxygen species (ROS) production in airway smooth muscle cells of severe asthma.
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Mitochondrial reactive oxygen species (ROS) mediate proliferation and cytokine release in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Cell biology 2014
Year: 2014
Mitochondrial reactive oxygen species and glycolysis in airway smooth muscle cell proliferation in COPD
Source: International Congress 2015 – Advances in the future treatment of COPD
Year: 2015
Reactive oxygen species regulate autophagy in COPD myotubes in vitro
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Uncoupling protein 3 content is decreased in skeletal muscle of patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 88s
Year: 2002
Systemic inflammation is associated with mitophagy signalling in skeletal muscle of COPD patients
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Mitochondrial ATP production rate of leg muscles in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 289s
Year: 2002
Effect of oxidative stress on mitochondrial function in airway smooth muscle (ASM) cells from COPD patients
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013
Dissociation between mitochondrial function and mitochondrial content in peripheral muscles of COPD patients
Source: Annual Congress 2007 - Advances in respiratory muscles
Year: 2007
TNF-α-induced NF-κB activation stimulates skeletal muscle glycolytic metabolism through activation of HIF-1α
Source: International Congress 2015 – New insights into lung disease pathogenesis
Year: 2015
Effects of exercise in skeletal muscle mitochondrial DNA content in COPD
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008
Reduced mitochondrial density in the quadriceps muscle of patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 621s
Year: 2006
Impaired skeletal muscle kynurenine metabolism in patients with COPD
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients
Source: Eur Respir J 2009; 33: 1045-1052
Year: 2009
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Exercise-induced oxidative stress and skeletal muscle injury in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 97s
Year: 2004
Altered muscle metabolism and muscle mass in patients with COPD
Source: International Congress 2017 – Neuromuscular consequences of respiratory diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept